Dementia Event
Thursday, 22nd February, 3.30pm

Genomics Medicine Ireland are delighted to present a keynote lecture by Professor Harry Vinters M.D., Distinguished Professor of Pathology and Laboratory Medicine of Neurology (Emeritus) and Chief of Neuropathology at UCLA Medical Center.

Title of Talk: Vascular and Genetic Risk Factors in Dementia: Insights Into Pathogenesis

Date: Thursday, 22nd February, 2018 at 3.30pm

Agenda:
3.30pm – Registration
4pm – Introduction by GMI
4.10pm – Keynote presentation by Prof. Vinters
4.50pm – Q&A
5.15 – Beer and wine reception

Please RSVP by 19th February.

Your Name: (required)

Your Email: (required)

Your Organisation: (required)

Yes, I'd like to attendNo, I won't be able to attend but please send Prof. Vinters' presentation

Please leave this field empty.

Location: Genomics Medicine Ireland, Floor 2, Building 4, Cherrywood Business Park, Dublin, D18 K7W4 (Across from Dell)

Please note, parking is limited so Public Transport via the Luas (Brides Glen) is encouraged. Parking is available in the GMI marked spots in the car park behind Dell. To access the car park, turn left before reaching the Dell building and the car park is on the right.

About Prof. Vinters

Professor Harry Vinters, M.D.

Professor. Harry V. Vinters graduated from the University of Toronto Medical School and trained in Neurology and Neuropathology at the University of Western Ontario Hospitals in London, Canada (1977-81), and Pediatric Neuropathology in Vancouver with Dr. Margaret Norman (1981). He subsequently completed a research fellowship, focusing on the neurobiology of the blood-brain barrier and cerebral microvascular disease, with Dr. Pasquale A. Cancilla at UCLA, where he has been on the faculty since 1985. He formerly held the Daljit S. and Elaine Sarkaria Chair in Diagnostic Medicine, and is Distinguished Professor of Pathology and Laboratory Medicine of Neurology (Emeritus), and has been Chief of the Section of Neuropathology at UCLA Medical Center since 1993.

Prof. Vinters has published over 500 articles, reviews and book chapters on various aspects of neuropathology, ranging from its clinical aspects to issues of molecular pathogenesis. He has also co-authored or edited five books, including a widely used textbook of neuropathology. In addition to his clinical and teaching activities, he has active research programs in several areas, including vascular dementias and the vascular component of Alzheimer disease (especially mediated through amyloid/congophilic angiopathy), neuropathologic substrates of pediatric epilepsy, stroke and cerebrovascular disease. He was the recipient (in 2002) of the Research Award of the Alzheimer’s Association of Los Angeles, Riverside and San Bernardino Counties. He served as Editor-in-Chief of ‘Brain Pathology’, a leading international journal of clinical and experimental neuropathology, from 2000-2006. In 2004-2005, he served as President of the American Association of Neuropathologists. He currently serves on several editorial boards of major scientific journals.